Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lyumjev vs Humalog in Pediatric T1D (PRONTO-Peds)
NCT03740919Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2019
- Primary completion
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 18
01
Overview
A Phase 3 trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Eli Lilly and Company. Started Apr 2019; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03740919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740919.